Q4 2017 Asterias Biotherapeutics Inc Earnings Call
Conference Call Asterias Biotherapeutics Inc
Asterias Biotherapeutics Inc Conference call or earnings call will be held on Mar 15, 2018 via an 800 number (toll-free). During the earnings conference call's session Asterias Biotherapeutics Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact Asterias Biotherapeutics Inc for this information
Schedule a teleconference with QCONF and get 5 free calls with our conference service.
Asterias is a clinical-stage biotechnology company focused on developing and commercializing novel therapies in the emerging fields of cell therapy and regenerative medicine. We have two core technology platforms. The first is an immunotherapy platform to teach cancer patients' immune systems to attack their tumors. The second is pluripotent stem cell platform. Pluripotent cells are a type of stem cell capable of becoming all of the cell types in the human body. We are focused on developing therapies to treat conditions with high unmet medical needs and inadequate available therapies, with an initial focus on the therapeutic areas of oncology and neurology. In October of 2013, we acquired intellectual property, cell lines, preclinical and clinical data, and other assets from Geron Corporation ("Geron") and also acquired rights to use certain human embryonic stem ("hES") cell lines and to practice certain patents from our parent company, BioTime, Inc. ("BioTime").Read more Conference Call